Results 161 to 170 of about 149,361 (217)

Time exploration of initiating letermovir for the prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. [PDF]

Chin Med J (Engl)
Zhang R, Zhu M, Wang L, Liao N, Xie X, Heng J, Cao Y, Hu X, Shi W, Bian Z, Cao W.   +10 more
europepmc   +1 more source

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers. [PDF]

Blood Cell Ther
Yakushijin K, Perram J, Ho A, Farzana T, Iida H, Lee JW, Inamoto Y, George B, Wu D, Suzuki R, Behfar M, Huang H, Asawapanumas T, Rowlings P, Poudyal BS, Santosa D, Gyi AA, Altangerel O, Wanitpongpun C, Gan GG, Iyama S, Iqbal S, Ramzi M, Khadwal A, Kato J, Sim J, Cheng J, Ma D, Chua YX, Okamoto S, Iida M, Fuji S.   +31 more
europepmc   +1 more source

First successful allogeneic hematopoietic stem cell transplantation in STING-associated vasculopathy of infancy-A case report. [PDF]

Mol Ther Adv
Yu U, Song A, Luo C, Luo C, Qin X, Huang X, Wang X, Lin Y, Zhou C, Zhang M, Chen J, Wang X.   +11 more
europepmc   +1 more source

Glycocalyx biomarkers as early predictors of endotheliopathy in pediatric and young adult hematopoietic stem cell transplantation patients. [PDF]

Front Oncol
Uchida K, Mahadeo KM, McArthur J, Avent Y, Hsu CW, Pan H, Elbahlawan L, Hines M, Sharma A, Tatevossian RG, Mahapatra S, Kumbaji M, Sheikh I, Li Y, Schadler K, Ghafoor S.   +15 more
europepmc   +1 more source

Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation. [PDF]

Immunotherapy
Wang Y, Wu J, Huang X, Xiao Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hematopoietic Stem-Cell Transplantation

New England Journal of Medicine, 2006
Hematopoietic stem-cell transplantation, which is used to treat both malignant and nonmalignant conditions, was first conceived more than 50 years ago, but problems associated with transplanting a nonsolid organ and modulating the immune response had to be solved before the procedure could be used clinically.
Copelan Edward A
exaly   +3 more sources

Hematopoietic Stem Cell Transplantation

Hospital Practice, 1993
The isolation, purification, and in vitro expansion of the hematopoietic stem cell have allowed pretransplant immunologic and genetic manipulation. As a result, rapid allogeneic or autologous hematologic reconstitution with minimal graft-versus-host disease is possible in patients receiving high-dose chemotherapy.
S, Jagannath, B, Barlogie, G, Tricot
openaire   +2 more sources

Mesenchymal Stem Cells and Hematopoietic Stem Cell Transplantation

Annals of the New York Academy of Sciences, 2003
Abstract: Techniques have recently beome available to isolate and grow mesenchymal progenitors and to manipulate their growth under defined in vitro culture conditions. As a result mesenchymal stem cells can be rapidly expanded to numbers that are required for clinical application.
Willem E, Fibbe, Willy A, Noort
openaire   +2 more sources